Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study

Table 3

Patients classified by symptoms intensity during the treatment phase.

	Day 0	Day 1	Day 5	Day 10	Day 20
HSV-1 herpes labialis group (N = 15)
Itching
Severe	2	0	0	0	0
Moderate	6	0	0	0	0
Mild	6	5	2	0	0
Absent	1	10	13	15	15
Burning
Severe	2	0	0	0	0
Moderate	8	0	0	0	0
Mild	4	5	2	0	0
Absent	1	10	13	15	15
Pain
Severe	0	0	0	0	0
Moderate	3	0	0	0	0
Mild	8	1	0	0	0
Absent	4	14	15	15	15
HSV-2 genital herpes group (N = 15)
Itching
Severe	1	2	0	0	0
Moderate	7	4	0	0	0
Mild	7	6	1	0	0
Absent	0	3	14	15	15
Burning
Severe	1	1	0	0	0
Moderate	8	2	0	0	0
Mild	5	10	1	0	0
Absent	1	2	14	15	15
Pain
Severe	1	1	0	0	0
Moderate	3	2	0	0	0
Mild	8	5	1	0	0
Absent	3	7	14	15	15

HSV: Herpes simplex virus.